Related references
Note: Only part of the references are listed.Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets
May H. Han et al.
NATURE (2008)
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
Barbara Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial
Amit Bar-Or et al.
ARCHIVES OF NEUROLOGY (2007)
Monocyte-derived dendritic cells in multiple sclerosis: The effect of bacterial infection
Jorge Correale et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes
Christopher E. Lowe et al.
NATURE GENETICS (2007)
Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis
Frida Lundmark et al.
NATURE GENETICS (2007)
Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis
Simon G. Gregory et al.
NATURE GENETICS (2007)
Risk alleles for multiple sclerosis identified by a genomewide study
David A. Hafler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inflammatory Multiple-Sclerosis Plaques Generate Characteristic Metabolic Profiles in Cerebrospinal Fluid
Norbert W. Lutz et al.
PLOS ONE (2007)
A specific viral cause of multiple sclerosis: One virus, one disease
Howard L. Lipton et al.
ANNALS OF NEUROLOGY (2007)
Interleukin-7 receptor expression: intelligent design
Renata Mazzucchelli et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Association between parasite infection and immune responses in multiple sclerosis
Jorge Correale et al.
ANNALS OF NEUROLOGY (2007)
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
HMDB: the human metabolome database
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2007)
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells
Eun Mi Hur et al.
NATURE IMMUNOLOGY (2007)
Multiple sclerosis: a complicated picture of autoimmunity
Henry F. McFarland et al.
NATURE IMMUNOLOGY (2007)
The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration
Stephen L. Hauser et al.
NEURON (2006)
Epstein-Barr virus and multiple sclerosis - Evidence of association from a prospective study with long-term follow-up
Gerald N. DeLorenze et al.
ARCHIVES OF NEUROLOGY (2006)
Charting protein complexes, signaling pathways, and networks in the immune system
A Bauch et al.
IMMUNOLOGICAL REVIEWS (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays
QL Zhen et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A data integration methodology for systems biology
D Hwang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosis
GH Fernald et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Antigen microarray profiling of autoantibodies in rheumatoid arthritis
W Hueber et al.
ARTHRITIS AND RHEUMATISM (2005)
Multiple sclerosis genetics: leaving no stone unturned
JR Oksenberg et al.
GENES AND IMMUNITY (2005)
An examination of MS candidate genes identified as differentially regulated in multiple sclerosis plaque tissue, using absolute and comparative real-time Q-PCR analysis
L Tajouri et al.
BRAIN RESEARCH PROTOCOLS (2005)
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression
A Chiocchetti et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis
S Cepok et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Anti-α4 integrin therapy for multiple sclerosis -: Mechanisms and rationale
GPA Rice et al.
NEUROLOGY (2005)
The zebrafish: A new model of T-cell and thymic development
DM Langenau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Plasma osteopontin levels in multiple sclerosis
M Comabella et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Transcription-based prediction of response to IFN beta using supervised computational methods
SE Baranzini et al.
PLOS BIOLOGY (2005)
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
V Viglietta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity
A Achiron et al.
ANNALS OF NEUROLOGY (2004)
Co-localization of differentially expressed genes and shared susceptibility loci in human autoimmunity
TM Aune et al.
GENETIC EPIDEMIOLOGY (2004)
Evidence for pathogenic heterogeneity in multiple sclerosis
CF Lucchinetti et al.
ANNALS OF NEUROLOGY (2004)
Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody
JW Rose et al.
ANNALS OF NEUROLOGY (2004)
An altered immune response to Epstein-Barr virus in multiple sclerosis -: A prospective study
P Sundström et al.
NEUROLOGY (2004)
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Functional immunomics: Microarray analysis of IgG autoantibody repertoires predicts the future response of mice to induce diabetes
FJ Quintana et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients
MHJ Vogt et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Advanced sequencing technologies: Methods and goals
J Shendure et al.
NATURE REVIEWS GENETICS (2004)
Toward rigorous comprehension of biological complexity: Modeling, execution, and visualization of thymic T-cell maturation
S Efroni et al.
GENOME RESEARCH (2003)
A meta-analysis of whole genome linkage screens in multiple sclerosis
JOURNAL OF NEUROIMMUNOLOGY (2003)
Genomic effects of IFN-β in multiple sclerosis patients
B Weinstock-Guttman et al.
JOURNAL OF IMMUNOLOGY (2003)
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis
WH Robinson et al.
NATURE BIOTECHNOLOGY (2003)
Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis
M Inglese et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Elevated osteopontin levels in active relapsing-remitting multiple sclerosis
MHJ Vogt et al.
ANNALS OF NEUROLOGY (2003)
Expression profiling identifies responder and non-responder phenotypes to interferon-β in multiple sclerosis
S Stürzebecher et al.
BRAIN (2003)
Osteopontin polymorphisms and disease course in multiple sclerosis
S Caillier et al.
GENES AND IMMUNITY (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis
AI Danilov et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Projection of an immunological self shadow within the thymus by the aire protein
MS Anderson et al.
SCIENCE (2002)
Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis
DT Chard et al.
BRAIN (2002)
Serum nitric oxide metabolites in patients with multiple sclerosis
B Nazliel et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2002)
The role of nitric oxide in multiple sclerosis
KJ Smith et al.
LANCET NEUROLOGY (2002)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease
WH Robinson et al.
CLINICAL IMMUNOLOGY (2002)
Autoantigen microarrays for multiplex characterization of autoantibody responses
WH Robinson et al.
NATURE MEDICINE (2002)
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas et al.
SCIENCE (2001)
Anti-aαB-crystallin immunoreactivity in inflammatory nervous system diseases
B Çelet et al.
JOURNAL OF NEUROLOGY (2000)